New expert consensus highlights the potential benefits and risks of GLP-1 medications for people with eating disorders and the need for careful screening and ongoing monitoring.
Trending
- Walmart “Gets” The Muppet Christmas Carol. Is Disney Missing an Opportunity?
- New Wreck-It Ralph Sugar Rush: Sweet Rescue Ride Opening Date & Launch Programs Announced
- Aaron Rodgers actually made a point about NFL international games fans need to hear
- Payton Pritchard’s offseason routine is the most intense thing you’ve ever heard
- The 7 biggest disappointments from the first week of the NBA season
- MLB Rumors: A wild Tarik Skubal sleeper and an even wilder Jazz Chisholm Jr. prediction
- Mike Vrabel ‘proud’ of Malik Willis ahead of Patriots-Dolphins game
- ‘Let my guys down’: Eagles’ Landon Dickerson blasts his performance in loss to Cowboys